A Guide to Primary Care of People with HIV/AIDS - Canadian Public ...
A Guide to Primary Care of People with HIV/AIDS - Canadian Public ...
A Guide to Primary Care of People with HIV/AIDS - Canadian Public ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
A <strong>Guide</strong> <strong>to</strong> <strong>Primary</strong> <strong>Care</strong> <strong>of</strong> <strong>People</strong> <strong>with</strong> <strong>HIV</strong>/<strong>AIDS</strong><br />
Chapter 12: Family Planning and Pregnancy<br />
12<br />
intercurrent STDs should be treated, and attempts <strong>to</strong><br />
conceive should be well timed around ovulation <strong>to</strong> avoid<br />
unnecessary exposures during periods <strong>of</strong> decreased<br />
fertility. The American College <strong>of</strong> Obstetricians and<br />
Gynecologists has recently endorsed the use <strong>of</strong><br />
reproductive technology in <strong>HIV</strong>-infected patients (ACOG,<br />
2004). Which patients should be <strong>of</strong>fered assisted<br />
reproduction and what the optimal methods are <strong>of</strong><br />
decreasing heterosexual and perinatal <strong>HIV</strong> transmission<br />
must be determined.<br />
When should pregnancy testing be done?<br />
Since most pregnancies are unplanned, the diagnosis <strong>of</strong><br />
pregnancy frequently occurs late in the first trimester,<br />
when organogenesis is nearly complete. In order <strong>to</strong><br />
make the diagnosis earlier, pregnancy tests should be<br />
done when sexually active women have:<br />
• Late or missed menses (unless she is using Norplant<br />
or Depo-Provera)<br />
• Irregular bleeding (unless she is using Norplant or<br />
Depo-Provera)<br />
• New onset <strong>of</strong> irregular bleeding after prolonged<br />
amenorrhea <strong>with</strong> Norplant/Depo-Provera<br />
• New onset <strong>of</strong> pelvic pain<br />
• Enlarged uterus or adnexal mass on exam<br />
In addition, women <strong>with</strong> the potential <strong>of</strong> becoming<br />
pregnant should be tested before starting potentially<br />
tera<strong>to</strong>genic therapies such as efavirenz (EFV), which<br />
is the only antiretroviral drug that is contraindicated<br />
in pregnancy. Patients should be alerted <strong>to</strong> potential<br />
tera<strong>to</strong>genic effects on the fetus, and suitable<br />
contraception should be prescribed.<br />
What contraceptive methods are recommended<br />
for women <strong>with</strong> <strong>HIV</strong> who do not want <strong>to</strong><br />
become pregnant?<br />
Condoms are the most common contraceptive method<br />
used by women living <strong>with</strong> <strong>HIV</strong>. Condoms, consistently<br />
used, have the added advantage <strong>of</strong> providing protection<br />
against STDs, including potential reinfection <strong>with</strong> <strong>HIV</strong>.<br />
This benefit should be emphasized when contraceptive<br />
advice is given <strong>to</strong> an <strong>HIV</strong>-positive or at-risk woman even<br />
if she is not seeking or does not need contraception but<br />
is sexually active.<br />
Hormonal methods <strong>of</strong> contraception are also frequently<br />
used (delivered orally, by injection, or by skin patch).<br />
However, there are many important drug interactions<br />
between hormonal contraceptives and drugs used <strong>to</strong><br />
treat <strong>HIV</strong> infection and <strong>HIV</strong>-related complications (see<br />
next question).<br />
What are the most common drug interactions<br />
between oral contraceptives and drugs used in<br />
<strong>HIV</strong> disease?<br />
Oral contraceptives significantly interact <strong>with</strong><br />
amprenavir/fosamprenavir (APV/FAPV), efavirenz (EFV),<br />
lopinavir (LPV), nelfinavir (NFV), nevirapine (NVP), and<br />
ri<strong>to</strong>navir (RTV); an additional method <strong>of</strong> contraception,<br />
such as condoms, is recommended. Similarly, other<br />
drugs commonly used by <strong>HIV</strong>-infected patients,<br />
including tetracycline, rifampin, oral anticoagulants,<br />
beta-blockers, and antidepressants interact <strong>with</strong><br />
oral contraceptives, and an additional means <strong>of</strong><br />
contraception is advisable. Indinavir and atazanavir do<br />
not appear <strong>to</strong> have an interaction.<br />
What contraceptive methods are not highly<br />
recommended for women <strong>with</strong> <strong>HIV</strong> who do not<br />
want <strong>to</strong> become pregnant?<br />
Spermicides: Generally, a spermicide should be<br />
used along <strong>with</strong> a barrier method <strong>to</strong> increase its<br />
effectiveness. However, in some studies nonoxynol-9<br />
(the active ingredient in spermicidal contraceptives)<br />
has been found <strong>to</strong> cause vaginal irritation and epithelial<br />
inflammation when used as the sole contraceptive<br />
method and on a regular and frequent basis. This may<br />
increase the risk <strong>of</strong> <strong>HIV</strong> transmission.<br />
Intrauterine Device: The intrauterine device (IUD) is<br />
not recommended for <strong>HIV</strong>-infected women. The IUD is<br />
associated <strong>with</strong> pelvic inflamma<strong>to</strong>ry disease and is also<br />
associated <strong>with</strong> increased menstrual flow. Some studies<br />
even suggest that this device is linked <strong>to</strong> increased<br />
susceptibility <strong>to</strong> <strong>HIV</strong> transmission.<br />
PREVENTING MOTHER-<br />
TO-CHILD TRANSMISSION<br />
(MTCT)<br />
Which are the current recommendations for<br />
<strong>HIV</strong> testing <strong>of</strong> pregnant women?<br />
Since prevention <strong>of</strong> vertical transmission (from mother<br />
<strong>to</strong> child) <strong>of</strong> <strong>HIV</strong> is so effective, identification <strong>of</strong> <strong>HIV</strong><br />
infection in all women who are pregnant is imperative.<br />
Therefore:<br />
• <strong>HIV</strong> testing should be a routine part <strong>of</strong> prenatal care<br />
for all women. The “opt out” method, in which <strong>HIV</strong><br />
testing is included in the routine bloodwork and<br />
pregnant women have <strong>to</strong> refuse the test, results in<br />
higher test rates and should be used.<br />
98<br />
U.S. Department <strong>of</strong> Health and Human Services, Health Resources and Services Administration, <strong>HIV</strong>/<strong>AIDS</strong> Bureau